產(chǎn)品名稱 WEHI164 from ACCEGEN BIOTECH
    產(chǎn)品貨號(hào) ABC-TC1284
    產(chǎn)品價(jià)格 現(xiàn)貨詢價(jià),電話:010-67529703
    產(chǎn)品規(guī)格 1 vial
    產(chǎn)品品牌 ACCEGEN BIOTECH
    產(chǎn)品概述
    產(chǎn)品詳情
    Edit&nbsp
    Product NameWEHI164
    Descriptionthis line was originally established by M. Rollinghoff and N.L. Warner from a fibrosarcoma induced by subcutaneous injections of 3-methylcholanthrene; after pretreatment with actinomycin D, the cells are highly sensitive to human cytotoxic monocytes, to human tumor necrosis factor and to lymphotoxin; they can be used as target cells for short term chromium release cytotoxicity assays; tested and found negative for ectromelia virus (mousepox)Tumorigenecity:Isoenzyme:Histopathology:fibrosarcomaSubculture:Split ratio:Media change:Reverse transcritase:Production
    Size1 vial
    Concentrationn/a
    Applicationsn/a
    Other Namesn/a
    Gene, Accession, CAS #n/a
    Catalog #ABC-TC1284
    Price
    Order / More InfoWEHI164 from ACCEGEN BIOTECH
    Product Specific Referencesn/a
    產(chǎn)品資料

    <strong id="itm00"><address id="itm00"></address></strong>
    <th id="itm00"></th>
    <acronym id="itm00"><label id="itm00"></label></acronym>
  1. <th id="itm00"></th>